Marking a milestone in advancing science, sharing knowledge, and shaping the next generation of blood cancer care.

Over the past 25 years, the Lymphoma, Leukemia & Myeloma Congress has transformed from a small, focused gathering into an international congress that drives innovation and connects experts from across the field. This year’s 25th anniversary event takes place October 14–17, 2025, at the Sheraton New York Times Square, and it feels like the perfect moment to reflect on how far we have come and where we are headed.

Anniversaries also make me think about other milestones, and for me that includes the Broadway opening of Left on Tenth one year ago. Delia Ephron’s best-selling memoir (you should read it!) tells her incredible story of navigating new love, a new husband, AML therapy, and a bone marrow transplant, all after turning 70.

I was part of her care team, and being featured as a doctor on a Broadway stage was a surreal experience. More than anything, it was a reminder of the resilience, hope, and human connection that run through our patients' journeys and a powerful testament to the pace of progress in treating hematological malignancies.

A Meeting That Has Grown with the Field

The past quarter century has brought extraordinary advancements in hematologic malignancies. We have gone from limited treatment options to a broad and rapidly expanding arsenal of targeted therapies, immunotherapies, and combination approaches. LL&M Congress has grown alongside these developments, expanding its agenda to cover not just the science, but the day-to-day realities of patient care.

One of the most exciting evolutions has been the increased involvement of younger clinicians, including fellows, early-career physicians, and Advanced Practice Providers. They bring fresh perspectives, new ideas, and a commitment to push the field forward.

As much as this year’s meeting is about honoring the past 25 years, it is also about preparing the next generation to lead the next 25.

What to Expect in 2025

The 2025 LL&M Congress offers a rich program of sessions across leukemia, lymphoma, and myeloma, alongside dedicated tracks for APPs and other care team members. Attendees can expect:

• Practical, case-based education you can apply immediately
• Updates on the latest clinical trial results and their implications for everyday practice
• Opportunities to collaborate across specialties and settings
• Discussion of emerging therapies such as CAR T-cell therapy and bispecific antibodies, with guidance on integrating them into patient care

I will be presenting “Practical Management Strategies for Older AML Patients” on Tuesday, October 14, from 8:25 to 8:45 AM, where I will share approaches for optimizing treatment efficacy, toxicity, and patient quality of life. My own session is just one part of an outstanding lineup.

Looking Ahead

Marking the 25th anniversary of LL&M Congress is not just about looking back. It is a call to keep advancing, to challenge ourselves, embrace innovation, and ensure that the gains of the past decades continue to translate into better outcomes for every patient. I hope you will join us in New York to learn, connect, and be part of the next chapter.

Event Details

• Meeting: LL&M Congress 2025
• Dates: October 14–17, 2025
• Location: Sheraton New York Times Square, New York City
• Featured Session: “Practical Management Strategies for Older AML Patients” Tuesday, October 14, 8:25 to 8:45 AM
• Event website
• Registration information

Gail J. Roboz, MD, is Professor of Medicine and Director, Leukemia Program at New York Presbyterian Hospital, Weill Cornell Medicine.